Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023)

Pulse Biosciences' (PLSE) quarterly Debt Ratio came in at 0.93 in Q1 2023, up 10.9% quarter-over-quarter from 0.83 in Q4 2022.

Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023) Analysis & Trends

Pulse Biosciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.93 for Q1 2023.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.93 in Q1 2023; TTM through Mar 2023 was 0.93, a N/A change from a year earlier, with the FY2022 full-year figure at 0.83, changed N/A from the prior year.
Debt Ratio climbed to 0.93 in Q1 2023 per PLSE's latest filing, from 0.83 in the prior quarter.
Across five years, Debt Ratio topped out at 0.93 in Q1 2023 and bottomed at 0.51 in Q1 2021.
The 3-year median for Debt Ratio is 0.79 (2022), against an average of 0.75.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	0.13
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	0.34
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	0.32
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	0.08
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	0.05
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	0.20
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	0.36
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Pulse Biosciences	2.09 Bn	2.01 Bn	-	-

Download Data